- $92.04m
- $73.52m
- $30.78m
- 69
- 60
- 56
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13 | 8.06 | 15.9 | 30 | 30.8 |
Cost of Revenue | |||||
Gross Profit | 6.16 | 3.62 | 9.92 | 19.6 | 21 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 23.2 | 41.9 | 17.4 | 27.4 | 31 |
Operating Profit | -10.2 | -33.8 | -1.49 | 2.63 | -0.198 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.1 | -32.7 | -1.3 | 2.84 | 0.264 |
Net Income After Taxes | -11.1 | -32.7 | -1.3 | 2.84 | 0.264 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.1 | -32.7 | -1.3 | 2.84 | 0.264 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.1 | -32.7 | -1.3 | 2.84 | 0.264 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.227 | -0.185 | -0.043 | 0.033 | 0.052 |